新世界百货中国(00825.HK)拟出售品牌管理及时装分销零售公司全部股权
格隆汇7月19日丨新世界百货中国(00825.HK)发布公告,2019年7月19日,公司全资附属达运企业有限公司作为卖方与新世界发展全资附属K11Sales&E-CommerceCompanyLimited订立协议,据此,卖方同意以代价100万港元购买出售目标公司WellMetroGroupLimited全部股权。
目标集团主要在中国从事品牌管理及时装及饰品的分销及零售。于2019年6月30日,目标公司未经审核的综合负债净值约为350万港元。
董事会拟将出售事项所得款项净额用作集团一般营运资金。监于现时市场情况,公司管理层决定出售事项,使集团能集中资源在核心百货店业务上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.